Serum amyloid A is present in the capillaries and microinfarcts of hypertensive monkey brain: An immunohistochemical study

Amyloid

Volumn 7, Issue 2, 2000, Pages 111-117

  Bartolák Suki, Erzsébet ^a   Sipe, Jean D ^a   Fine, Richard E ^a   Rosene, Douglas L ^a   Moss, Mark B ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cognitive decline; Endothelium; Inflammation; Microglia; Myelin

Indexed keywords

ACUTE PHASE PROTEIN; SERUM AMYLOID A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN INJURY; CAPILLARY ENDOTHELIUM; COGNITION; CONTROLLED STUDY; ENDOTHELIUM CELL; HYPERTENSION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MONKEY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL;

EID: 0034029380     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.3109/13506120009146247     Document Type: Article

References (49)

1. Eriksen N, Meek RL and Benditt EP (1993). The SAA lipoprotein family. In Mackiewitz A, Kushner, Baumann IH, eds. Acute Phase Proteins: Molecular Biology, Biochemistry and Clinical Applications. Boca Raton, FL, CRC Press, pp. 93-106
2. Hoffman JS and Benditt EP (1982). Changes of high density lipoprotein content following endotoxin administration in the mouse: formation of serum amyloid protein-rich subfractions. J Biol Chem 257, 10510-10517
3. Kushner I (1982). The phenomenon of the acute phase response. Ann NY Acad Sci 389, 39-48.
4. Husbey G, Marhaug G, Dowton B, Sletten K and Sipe JD (1994). Serum amyloid A (SAA): biochemistry, genetics and the pathogenesis of AA amyloidosis. Amyloid Int J Exp Clin Invest 1, 119-137
5. Steel DM and Whitehead AS (1994). The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 15, 81-88
6. Betts JC, Edbrooke MR, Thakker RV and Woo P (1991). The human acute-phase serum amyloid A gene family: structure, evolution and expression in hepatoma cells. Scand J Immunol 34, 471-482
7. Raynes JG, Eagling S and McAdam KP (1991). Acute-phase protein synthesis in human hepatoma cells. Differential regulation of serum amyloid A (SAA) and haptoglobin by interleukin-1 and interleukin-6. Clin Exp Immunol 83, 488-491
8. Grehan S, Uhlar CM, Sim RB, Herbert J and Whitehead AS (1997). Expression of a biologically active recombinant mouse IL-1 receptor antagonist and its use in vivo to modulate aspects of the acute phase response. J Immunol 159, 369-78
9. Jiang SL, Lozanski G, Samols D and Kushner I (1995). Induction of human serum amyloid A in Hep 3B cells by IL-6 and IL-1 beta involves both transcriptional and post-transcriptional mechanisms. J Immunol 154, 825-31
10. Lozanski G, Jiang SL, Samols D and Kushner I (1996). C-reactive protein and serum amyloid A mRNA stability following induction by cytokines. Cytokine 8, 534-40
11. Rokita H, Loose LD, Bartle LM and Sipe JD (1994) Synergism of interleukin-1 and interleukin-6 induces serum amyloid A production while depressing fibrinogen: a quantative analysis. J Rheumatology 21, 400-405
12. Rygg M (1996). Cytokine-induced differential expression of serum amyloid A genes in fetal and neonatal rabbits. Clinical & Experimental Immunology 103, 335-42
13. Meek RL and Benditt EP (1989). Rat tissues express serum amyloid A protein-related mRNAs. Proc Natl Acad Sci USA 86, 1890-1894
14. Meek RL, Urieli-Shoval S and Benditt EP (1994). Expression of apolipo-protein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. Proc Natl Acad Sci USA 91, 3186-3190
15. Ramadori RG, Sipe JD and Colten HR (1985). Expression and regulation of the murine serum amyloid A (SAA) gene in extrahepatic sites. J Immunol 135, 3645-3647
16. Webb CF, Tucker PW and Dowton SB (1989). Expression and sequence analysis of serum amyloid A in the Syrian hamster. Biochemistry 28, 4785-4790
17. Aldo-Benson MA and Benson MD (1982). SAA suppression of immune response in vitro: evidence for an effect on T cell-macrophage interaction. J Immunol 128, 2390-2392
18. Brinckerhoff CE, Mitchell TI, Karmilowicz MJ, Kluve-Beckerman B and Benson MD (1989). Autocrine induction of collagenase by serum amyloid A-like and B2-microplugin-like proteins. Science 243, 655-657
19. Zimlichman S, Danon A, Nathan I, Mozes G and Shainkin-Kestenbaum R (1990). Serum amyloid A, an acute phase protein, inhibits platelet activation. J Lab Med 116, 180-186
20. Baumberger C, Ulevitch RJ and Dayer JM (1991). Modulation of endotoxic activity of lipopolysaccharide by high density lipoprotein. Pathobiology 59, 378-383
21. Linke RP, Bock V, Valet G and Rome G (1991). Inhibition of the oxidative burst response of N formyl peptide-stimulated neutrophils by serum amyloid A protein. Biochem Biophys Res Commun 176, 1100-1105
22. Kisilevsky R and Subrahmanyan L (1992). Serum amyloid A changes high density lipoprotein's cellular affinity. A clue to serum amyloid A's principal function. Lab Invest 66, 778-785
23. Preciado-Patt L, Levartowsky D, Pras M, Hershkoviz R, Lider O and Fridkin M (1994). Inhibition of cell adhesion to glycoproteins of the extracellular matrix by peptides corresponding to serum amyloid A. Toward understanding the physiological role of an enigmatic protein. Eur J Biochem 223, 35-42
24. Badolato R, Wang JM, Murphy WJ, Lloyd AR, Michiel DF, Bausserman LL, Kevin DJ and Oppenheim JJ (1994). Serum amyloid A is a chemoattractant: induction of migration, adhesion and tissue infiltration of monocytes and polymorphonuclear leukocytes. J Exp Med 180, 203-209
25. Hardardottir I, Sipe JD, Moser AH, Fielding CJ, Feingold KR and Grunfeld C (1977). LPS and cytokines regulate extra hepatic mRNA levels of apolipoproteins during the acute phase response in Syrian hamster. Biochim Biophys Acta 1344, 210-220
26. Liang JS, Sloane JA, Wells JM, Abraham CR, Fine RE and Sipe JD (1997). Evidence for local production of acute phase response apolipoprotein serum amyloid A in Alzheimer's disease brain. Neuroscience Lett 225, 73-76
27. Elias MF, Wolf PA, D'Agostino RB, Cobb G and White LR (1993). Untreated blood pressure level is inveresely related to cognitive functioning: the Framingham study. Am J Epidemiol 138, 353-364
28. Waldstein SR (1995). Hypertension and neuropsychological function: a lifespan perspective. Exp Aging Res 21, 321-352
29. Kemper TL, Moss MB, Hollander W and Prusty S (1999). Microinfraction as a result of hypertension in a primate model of cerebrovascular disease. Acta Neuropath 98, 295-303
30. Moss MB, Rosene DL, Kemper TL, Prusty S and Hollander W (1993). Hypertension-induced memory impairment and microinfraction in monkeys. Soc Neurosci Abstr 19, 196
31. Moss MB (1999). A primate model of hypertensive cerebrovascular disease. In: Innovative Animal Models of CNS Diseases: From molecule to therapy, DF Emerich and E.L Dean (Eds) Humana Press, Totowa N.J., (in press)
32. Hollander W, Madoff I, Paddock J and Kirkpatrick B (1976). Aggravation of atherosclerosis by hypertension in a subhuman primate model with coarctation of the aorta. Circ Res 38 (Suppl II), 63-72
33. Hollander W, Prusty S, Kirkpatrick B, Paddock J and Nagrai S (1977). Role of hypertension in ischemic heart disease and cerebral vascular disease in the cynomolgus monkey with coarctation of the aorta. Circ Res 40 (Suppl I), I-70-I-83
34. Godenir NL, Jeenah MS, Coetzee GA, van der Westhuyzen DR, Strachan AF and de Beer FC (1985). Standardization of the quantitation of serum amyloid A protein (SAA) in human serum. J Immunol Methods 83, 217-225
35. Urieli-Shoval S, Meek RL, Hanson RH, Eriksen N and Benditt EP (1994). Human serum amyloid A genes are expressed in monocyte/macrophage cell lines. Am J Pathol 145, 650-660
36. Chu CJ, Lee FY, Chang FY, Wang SS, Lin HC, Wu SL, Tai CC and Lee SD (1997). Hyperdynamic circulation in prehepatic portal hypertension: role of tumor necrosis factor-alpha. Chung Hua i Hsueh Tsa Chih-Chinese Medical J 59, 145-50
37. Kawai Y, Matsumoto Y, Watanabe K, Yamamoto H, Satoh K, Murata M, Handa M and Ikeda Y (1996). Hemodynamic forces modulate the effects of cytokines on fibrinolytic activity of endothelial cells. Blood 87, 2314-21
38. Kuehn BE, Hoff WJ and Wallock ME (1995). Cardiopulmonary bypass with adequate flow and perfusion pressures prevents endotoxaemia and pathologic cytokine production. Perfusion 10, 27-31
39. Nerem RM, Alexander RW, Chapell DC, Medford RM, Varner SE and Taylor WR (1998). The study of the influence of flow on vascular endothelial biology. Am J Med Sciences 316, 169-75
40. Bouloumine A, Bauersachs J and Linz W (1997). Endothelial dysfunction coincides with an enhanced nitric oxide synthase expression and superoxide anion production. Hypertension 30, 1628-1633
41. Chou TZC, Yen M-H and Li C-Y (1998). Alterations to nitric oxide synthase expression with aging and hypertension. Hypertension 31, 643-648
42. Kontos HA, Wei EP and Navari RM (1978). Responses of cerebral arteries and arterioles to acute hypotension and hypertension. Am J Physio. 234, H371-383
43. Kontos HA (1985). Oxygen radicals in cerebral vascular injury. Circ Res 57, 508-516
44. Singh A, Sventek P, Lariviere R, Thibault G and Schiffrin EL (1996). Inductible nitric oxide synthase in vascular smooth muscle cells from prehypertensive spontaneously hypertensive rats. Am J Hypertension 9, 867-77
45. Keffer J, Probert L, Cazlaris H, Georgopoulos S, Kaslaris, Kioussis D and Kollias G (1991). Transgenic mice expressing human tumor necrosis factor, a predictive genetic model of arthritis. EMBO J 10, 4025-4031
46. Schwab JH, Anderle SK, Brown RR, Dalldorf FG and Thompson RC (1991). Pro-and anti-inflammatory roles of interleukin-1 in recurrence of bacterial cell wall-induced arthritis in rats. Infect Immun 59, 4436-4442
47. Sipe JD (1992). Amyloidosis. Annu Rev Biochem 61, 947-975
48. Liang JS, Schreiber BM, Salmona M, Phillip G, Gonnerman WA, de Beer FC and Sipe JD (1996). Amino terminal region of acute phase, but not constitutive, serum amyloid A (apoSAA) specifically binds and transports cholesterol into aortic smooth muscle and Hep G2 cells, J Lipid Res 37, 2109-2116
49. Schreiber BM, Veverbrants M, Fine RE, Blusztajn JK, Salmona M, Patel A and Sipe JD (1999). Apolipoprotein serum amyloid A (SAA) down regulates smooth muscle cell lipid biosynthesis. J Biochem 344, 7-13